Golimumab and certolizumab pegol for the treatment of hidradenitis suppurativa: a literature review and future perspective

• Main Authors: Amirhossein Heidari (Author), Yekta Ghane (Author), Nazila Heidari (Author), Seyedayin Hosseini (Author), Azadeh Goodarzi (Author)
• Format: Book
• Published: SAGE Publishing, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hidradenitis suppurativa (HS) is an inflammatory skin condition with an underlying inflammatory process. Due to the limited efficacy of available treatments, HS remains a therapeutic challenge. The safety and efficacy of tumor necrosis factor-α (TNF-α) inhibitors, adalimumab, infliximab, and etanerc...